TP53 p.Ser241Phe
c.722C>T · rs28934573 · VCV12359
Computational evidence
| Protein change | ||
| AlphaMissense | 0.999 | likely pathogenic ✓ concordant with ClinVar · top 3% in TP53 |
|---|---|---|
| REVEL | 0.958 | strongly pathogenic-leaning |
| SaProt | LLR -13.21 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 0.16, phastCons 1 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 6,982 bp · p 0.0085 · regional, not allelic |
| Overall | ||
| CADD | 27.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- TP53
- Protein
- p.Ser241Phe
- Coding
- c.722C>T
- MANE Select
- NM_000546
- dbSNP
- rs28934573
- Type
- single nucleotide variant
- Location
- chr17:7674241 (GRCh38)
- Gene constraint
- LOEUF 0.449 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 75.83 · 321 PDB
- Residue 241
- a DNA-binding region; the 'interaction with axin1' region; the 'interaction with the 53bp2 sh3 domain' region; an α-helix; the 'interaction with ccar2' region; the 'interaction with hipk1' region; the 'required for interaction with znf385a' region; a UniProt-annotated variant site (in sporadic cancers; somatic mutation); a UniProt-annotated variant site (in lfs; germline mutation and in sporadic cancers; somatic mutation)
Disease context
Li-Fraumeni syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: bone osteosarcomaexocrine pancreatic carcinomacolorectal cancerhepatocellular carcinomaadrenocortical carcinoma, hereditarychoroid plexus papillomabasal cell carcinoma, susceptibility to, 7hereditary neoplastic syndromenasopharyngeal carcinomahereditary breast carcinomahepatoblastomaovarian neoplasmlip and oral cavity carcinomaglioma susceptibility 1bone marrow failure syndrome 5
For Li-Fraumeni syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- All ages
- Prevalence
- 1-9 / 100 000 (United Kingdom)
Similar variants
- TP53 p.Ser241Ala Pathogenic/Likely pathogenic ★★ same residue
- TP53 p.Ser241Cys Pathogenic/Likely pathogenic ★★ same residue
- TP53 p.Ser241Thr Pathogenic/Likely pathogenic ★★ same residue
- TP53 p.Ser241Tyr Pathogenic/Likely pathogenic ★★ same residue
- TP53 p.Ser241= Benign/Likely benign ★★ same residue
- TP53 p.Ser241Pro Uncertain significance ★ ⚠ same residue
- TP53 p.Ser241fs Pathogenic ★ same residue
- TP53 c.375+5G>A Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tp53-p-ser241phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown